Alterations in the expression and function of NKCC1 have been implicated in several brain disorders, including neonatal seizures, epilepsy, autism, cerebral edema following ischemic and traumatic brain injury, and in chronic and acute pain1,3–5. The gene discussed is SLC12A2; the disease is brain disorder.